Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |